Ardelyx reported $1.83B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
Amgen USD 184.41B 32.48B Feb/2026
Ardelyx USD 1.33B 390M Sep/2025
aTyr Pharma USD 60M 11M Feb/2026
Corcept Therapeutics USD 8.76B 977M Sep/2025
Sanofi EUR 118.94B 1.6B Feb/2026
TG Therapeutics USD 5.74B 21M Sep/2025
United Therapeutics USD 18.96B 6B Sep/2025